Table 3 Retinal detachment and surgical repair characteristics
|  | High ADI (n = 6) | Low ADI (n = 12) | P value |
|---|---|---|---|
Viral retinitis active at time of RD | 5 (83%) | 7 (58%) | 0.60 |
Macular involvement | 4 (67%) | 4 (33%) | 0.32 |
Foveal involvement | 2 (33%) | 3 (25%) | 1.00 |
Proliferative vitreoretinopathy | 3 (50%) | 3 (25%) | 0.34 |
Type of primary surgery | |||
 PPV | 3 (50%) | 6 (50%) | 1.00 |
 PPV/SB | 3 (50%) | 5 (42%) |  |
 SB | 0 (0%) | 1 (8%) |  |
Other adjuncts | |||
 Endolaser | 6 (100%) | 11 (92%) | 1.00 |
 Cryotherapy | 0 (0%) | 1 (8%) |  |
Membrane Peeling | 3 (50%) | 5 (42%) | 0.62 |
Tamponade | |||
 SF6 | 1 (17%) | 5 (42%) | 0.51 |
 C3F8 | 0 (0%) | 1 (8%) |  |
 Silicone oil | 5 (83%) | 5 (42%) |  |
 None | 0 (0%) | 1 (8%) |  |
Silicone oil removal | 1 (20%) | 4 (80%) | 0.21 |
Time to silicone oil removal, median (IQR) | 3.0 | 6.5 (5.0, 8.0) | 0.13 |
Phacoemulsification + IOL during silicone oil removal | 1 (17%) | 2 (17%) | 0.31 |